The Audit Committee aims to assist the Board of Directors in overseeing the quality and integrity of the company's execution of accounting, auditing, financial reporting processes, and financial controls.

The Audit Committee assists the Board in fulfilling its oversight of the quality and integrity of the accounting, auditing, reporting, and financial control practices of the Company. The Audit Committee is responsible for reviewing the Company’s financial reports, auditing and accounting policies and procedures, internal control systems, material asset or derivatives transactions, material lending funds, endorsements or guarantees, offering or issuance of any equity-type securities, legal compliance, and the hiring or dismissal of an attesting CPA, etc. TaiMed’s Audit Committee consists of all independent Directors, and Professor Chin-Ting Chiu serves as the chairman of the committee. Please refer to TaiMed’s Annual Report for the relevant year for the number of meetings convened and each member’s attendance rate..

Chairman Chiu, Chin-Ting

  • MBA, National Taiwan University
  • chairman, Securities and Futures Investors Protection Center
  • member of Mediation Committee, Securities and Futures Investors Protection Cente

Member Howard S. Lee, Ph.D.

  • PhD in Chemistry, University of Southern California, USA
  • Partner, The CID Group
  • Chairman, Easywell Biomedicals, Inc.
  • Chairman, TAHO Pharmceuticals, Ltd.
  • Chairman, Transwell Biotech CO., Ltd.

Member Gwo-Fong Lin, Ph.D

  • Doctor of Philosophy in Engineering, University of Pittsburgh
  • Distinguished Professor, National Taiwan University
  • Corresponding Member, International Academy of Engineering, Russi